BTLA Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag)
Quick Overview for BTLA Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag) (ABIN2713580)
Target
See all BTLA ProteinsProtein Type
Origin
Source
Application
Purity
-
-
Protein Characteristics
- Transcript Variant 1
-
Purification tag / Conjugate
- This BTLA protein is labelled with Myc-DYKDDDDK Tag.
-
Characteristics
-
- Recombinant human CD272 / BTLA (transcript variant 1) protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays -
Comment
-
The tag is located at the C-terminal.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 50 μg/mL
-
Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
-
Storage
- -80 °C
-
Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
-
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Alternative Name
- Cd272,btla
-
Background
- This gene encodes a member of the immunoglobulin superfamily. The encoded protein contains a single immunoglobulin (Ig) domain and is a receptor that relays inhibitory signals to suppress the immune response. Alternative splicing results in multiple transcript variants. Polymorphisms in this gene have been associated with an increased risk of rheumatoid arthritis.
-
Molecular Weight
- 32.6 kDa
-
NCBI Accession
- NP_861445
-
Pathways
- Cancer Immune Checkpoints
Target
-